FDA safety alert: Efficacy concerns for a combination therapy in breast cancer treatment

Experts release first clinical guidance on polygenic risk scores for breast cancer, outlining integration into screening and prevention strategies.

Wendie Berg, MD, PhD, explains new breast density reporting standards, cancer risks, and the importance of supplemental imaging for dense breast tissue.

In a recent study, older women receiving messages about breast cancer screening cessation were more likely to support stopping screening than those who did not receive a message.

A recent study found that hormone therapy use in breast cancer patients aged 65 years and older is associated with a reduced risk of Alzheimer's and related dementias.

A recent study from France demonstrates that incorporating hepatitis C virus screening into breast cancer programs significantly improves patient engagement and access to effective antiviral treatments among older women.

A recent study reveals that non-Hispanic White women living in deprived neighborhoods face higher breast cancer mortality, highlighting the impact of social determinants on health outcomes.